IP Library Patent Application 17775071
Patent Application
App. No. 17/775,071

ANTIPERSPIRANT FORMULATIONS COMPRISING HEMISQUALANE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/775,071
Abstract

Provided herein antiperspirant composition formulations that contain hemisqualane and lack organosilicon compounds. The hemisqualane provides the carrier and emollient activities that are typically supplied by an organosilicon compound. The antiperspirant formulations provided herein have a benefit of not releasing organosilicon compounds into the environment during and after their use.

Claims (27)

1 . An antiperspirant formulation comprising hemisqualane.

2 . The antiperspirant formulation of claim 1 , further comprising one or more solid dry-feel particles.

3 . The antiperspirant formulation of claim 2 , wherein the solid dry-feel particle is a solid absorbent particle.

4 . The antiperspirant formulation of claim 2 , wherein the solid dry-feel particle is a solid adsorbent particle.

5 . The antiperspirant formulation of claim 1 , wherein the antiperspirant is not an aerosol.

6 . The antiperspirant formulation of claim 1 , wherein the formulation does not contain an organosilicon compound.

7 . The antiperspirant formulation of claim 6 , wherein the organosilicon compound is a cyclomethicone.

8 . The antiperspirant formulation of claim 7 , wherein the cyclomethicone is cyclotetrasiloxane (D4).

9 . The antiperspirant formulation of claim 7 , wherein the cyclomethicone is cyclopentasiloxane (D5).

10 . The antiperspirant formulation of claim 7 , wherein the cyclomethicone is cyclohexasiloxane (D6).

11 . The antiperspirant formulation of claim 4 , wherein the solid adsorbent particle comprises from about 0% to about 5% of the formulation.

12 . The antiperspirant formulation of claim 4 , wherein the one or more solid adsorbent particle is selected from polymer-based microspheres, allyl methacrylates crosspolymers, lauryl methacrylate/glycol dimethacrylate crosspolymer, silica, and talc.

13 . The antiperspirant formulation of claim 1 further comprising an active ingredient.

14 . The antiperspirant formulation of claim 13 , wherein the active ingredient comprises an aluminum salt.

15 . The antiperspirant formulation of claim 13 , wherein the active ingredient is selected from aluminum chloride; aluminum chlorohydrate; aluminum chlorodydrex; aluminum chlorohydrex propylene glycol; aluminum dichlorodhydrate; aluminum dichlorodhydrex polyethylene glycol; aluminum dichlorohydrex propylene glycol; aluminum sesquichlorohydrate; aluminum sesquichlorohydrex propylene glycol; aluminum zirconium octachlorohydrate; aluminum zirconium octachlorohydrex gly.; aluminum zirconium pentachlorohydrate; aluminum zirconium pentachlorohydrex gly; aluminum zirconium tetrachlorohydrate; aluminum zirconium tetrachlorohydrex gly; aluminum zirconium trichlorohydrate; and aluminum zirconium trichlorohydrex gly.

16 . The antiperspirant formulation of claim 15 , wherein the active ingredient is aluminum zirconium tetrachlorohydrex glycine.

17 . The antiperspirant formulation claim 13 , wherein the active ingredient comprises from about 0.1% to about 30% (w/w).

18 . The antiperspirant formulation of claim 17 , wherein the active ingredient comprises from about 10% to about 25% (w/w).

19 . The antiperspirant formulation of claim 18 , wherein the active ingredient comprises from about 16% to about 20%.

20 . The antiperspirant formulation of claim 19 , wherein the active ingredient comprises about 18% (w/w).

21 . The antiperspirant formulation of claim 1 further comprising one or more inactive ingredients.

22 . The antiperspirant formulation of claim 21 , wherein the one or more inactive ingredients are selected from wax, emulsifier, emollient, moisturizer, anti-bacterial agent, preservative, humectant, buffer, color, and fragrance.

23 . The antiperspirant formulation of claim 1 , wherein hemisqualane comprises from about 1% to about 80% (w/w) of the antiperspirant formulation.

24 . The antiperspirant formulation of claim 23 , wherein the hemisqualane comprises from about 25% to about 75% (w/w) of the antiperspirant formulation.

25 . A method of preventing perspiration comprising applying an antiperspirant comprising the antiperspirant formulation of claim 1 to an area of skin in need of application.

26 . The method of claim 25 , wherein the antiperspirant is applied at least once every 24 hours.

27 . The method of claim 25 , wherein the antiperspirant is applied only once every 24 hours.

Assignments (5)
SECURITY INTEREST Recorded May 24, 2024
From: AMYRIS, INC.
To: EUAGORE, LLC
Reel/Frame 067528/0467 →
SECURITY INTEREST Recorded Aug 17, 2023
From: AMYRIS, INC.; AMYRIS CLEAN BEAUTY, INC.; AMYRIS FUELS, LLC; AB TECHNOLOGIES LLC; APRINNOVA, LLC; AMYRIS-OLINKA, LLC; ONDA BEAUTY INC.; UPLAND 1 LLC; AMYRIS ECO-FAB LLC; CLEAN BEAUTY 4U HOLDINGS, LLC; AMYRIS CLEAN BEAUTY LATAM LTDA; INTERFACES INDUSTRIA E COMERCIA DE COSMETICOS LTDA; AMYRIS BIOTECHNOLOGIA DO BRASIL LTDA; AMYRIS EUROPE TRADING B.V. (NETHERLANDS); AMYRIS BIO PRODCUTS PORTUGAL, UNIPESSOAL, LDA; BEAUTY LABS INTERNATIONAL LIMITED; AMYRIS UK TRADING LIMITED
To: EUAGORE, LLC
Reel/Frame 064619/0778 →
SECURITY INTEREST Recorded Aug 3, 2023
From: AMYRIS CLEAN BEAUTY, INC.; AMYRIS FUELS, LLC; AB TECHNOLOGIES LLC; AMYRIS, INC.
To: MUIRISC, LLC
Reel/Frame 064492/0518 →
SECURITY INTEREST Recorded Oct 18, 2022
From: AMYRIS, INC.
To: FORIS VENTURES, LLC
Reel/Frame 061703/0499 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2022
From: CHAN, DIVA; OTERI, RO; NUNES, ASHLEE
To: AMYRIS, INC.
Reel/Frame 059843/0186 →